Journal of global health · 2026
Global prevalence of iron deficiency anaemia among children aged 5-12 years: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sukwuttichai Pattarapan, Tidwong Nattapong, Chaipichit Natapohn, Dhippayom Teerapon, Dilokthornsakul Witoo, Dilokthornsakul Piyameth
Аннотация
BACKGROUND: Iron deficiency anaemia (IDA) can lead to impairment of immunity, cognitive function, and poorer academic performance. Current health policies worldwide focus primarily on IDA prevention among preschoolers and women, overlooking school-aged children (aged 5-12 years) as a susceptible group. Through this systematic review and meta-analysis, we aimed to determine the prevalence of IDA among this population.
METHODS: We searched PubMed, Embase, CINAHL, and EBSCO Open Dissertation from inception until July 2023 for English-language observational studies reporting on the prevalence of IDA children aged 5-12. We calculated the pooled prevalence using a random-effect model and performed subgroup analyses by regions, countries' income, and diagnostic criteria. We assessed the study quality using Hoy's risk of bias tool.
RESULTS: We included 55 studies involving over 2.1 million children. None of these studies had a high risk of bias. The pooled global prevalence of IDA among children aged 5-12 years in community settings was 9.4% (95% confidence interval = 6.5%, 12.7%, I2 = 99.6%). Subgroup analyses indicated moderate public health concerns among sub-Saharan Africa (21.9%) and South Asia (15.8%), or among low-income (29.7%) and lower-middle-income (24.5%) countries.
CONCLUSIONS: IDA is an important public health issue among children aged 5-12 years globally which even poses a significant concern in some populations or regions. Our findings could guide the development of national detection strategies and health prevention programmes targeted at improving children's health and educational outcomes.
REGISTRATION: PROSPERO (CRD42022335700).
METHODS: We searched PubMed, Embase, CINAHL, and EBSCO Open Dissertation from inception until July 2023 for English-language observational studies reporting on the prevalence of IDA children aged 5-12. We calculated the pooled prevalence using a random-effect model and performed subgroup analyses by regions, countries' income, and diagnostic criteria. We assessed the study quality using Hoy's risk of bias tool.
RESULTS: We included 55 studies involving over 2.1 million children. None of these studies had a high risk of bias. The pooled global prevalence of IDA among children aged 5-12 years in community settings was 9.4% (95% confidence interval = 6.5%, 12.7%, I2 = 99.6%). Subgroup analyses indicated moderate public health concerns among sub-Saharan Africa (21.9%) and South Asia (15.8%), or among low-income (29.7%) and lower-middle-income (24.5%) countries.
CONCLUSIONS: IDA is an important public health issue among children aged 5-12 years globally which even poses a significant concern in some populations or regions. Our findings could guide the development of national detection strategies and health prevention programmes targeted at improving children's health and educational outcomes.
REGISTRATION: PROSPERO (CRD42022335700).